Skip to content
healthcare.dev

EstroPRO Homeopathic Organotherapy

NDC 43853-0038, Agnus Castus, Angelica Sin, Apis Mel, Cimicifuga Rac, Estradiol, Estriol, Folliculinum, Galium, Glycyrrhiza, Oophorinum, Progesterone, Sepia, spray, from ProBlen.

Product NDC
43853-0038
Status
Listed
Labeler
ProBlen
Dosage form
SPRAY
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/43853-0038 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CHASTE TREE3 [hp_X]/mL
  • ANGELICA SINENSIS ROOT3 [hp_X]/mL
  • APIS MELLIFERA6 [hp_X]/mL
  • BLACK COHOSH3 [hp_X]/mL
  • ESTRADIOL9 [hp_C]/mL
  • ESTRIOL9 [hp_C]/mL
  • ESTRONE9 [hp_C]/mL
  • GALIUM APARINE3 [hp_X]/mL
  • GLYCYRRHIZA GLABRA3 [hp_X]/mL
  • SUS SCROFA OVARY30 [hp_C]/mL
  • PROGESTERONE6 [hp_X]/mL
  • SEPIA OFFICINALIS JUICE30 [hp_C]/mL

Pharmacologic classes

Allergens [CS]; Allergens [CS]; Bee Venoms [CS]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Estradiol Congeners [CS]; Estrogen Receptor Agonists [MoA]; Estrogen [EPC]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Non-Standardized Food Allergenic Extract [EPC]; Non-Standardized Plant Allergenic Extract [EPC]; Plant Proteins [CS]; Progesterone [CS]; Progesterone [EPC]; Standardized Insect Venom Allergenic Extract [EPC]

Package NDCNDC-11Package
43853-0038-14385300380130 mL in 1 BOTTLE, SPRAY (43853-0038-1)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 43853-0038 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/43853-0038 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 43853-0038. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.